Hepatocyte-specific gene expression from integrated lentiviral vectors

Journal of Gene Medicine

Volumn 6, Issue 9, 2004, Pages 974-983

  Nash, Kathryn L ^a   Jamil, Bushra ^a,b   Maguire, Alison J ^a   Alexander, Graeme J M ^a   Lever, Andrew M L ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b AGA KHAN UNIVERSITY   (Pakistan)

Author keywords

Enhancer; Gene therapy; Hepatitis B; Promoter

Indexed keywords

ALPHA 1 ANTITRYPSIN; GREEN FLUORESCENT PROTEIN; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; LENTIVIRUS VECTOR;

ARTICLE; CELL BASED GENE THERAPY; CYTOMEGALOVIRUS; ENHANCER REGION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE REPRESSION; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LIVER CELL CULTURE; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; VIRUS GENOME; VIRUS REPLICATION;

ALPHA 1-ANTITRYPSIN; ARTIFICIAL GENE FUSION; CELL LINE; CYTOMEGALOVIRUS; ENHANCER ELEMENTS (GENETICS); GENE EXPRESSION REGULATION, VIRAL; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENES, REPORTER; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HEPATITIS B VIRUS; HEPATOCYTES; HIV-1; HUMANS; PROMOTER REGIONS (GENETICS); TRANSDUCTION, GENETIC; TRANSFECTION; VIRUS INTEGRATION;

CUCUMBER MOSAIC VIRUS; CYTOMEGALOVIRUS; HEPATITIS B VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 11844252183     PISSN: 1099498X     EISSN: 15212254     Source Type: Journal    
DOI: 10.1002/jgm.591     Document Type: Article

References (41)

1. Wu GY, Wu CH. Receptor-mediated in vitro gene transformation by a soluble DNA carrier system. J Biol Chem 1987; 262: 4429-4432.
2. Protzer U, Nassal M, Chiang PW, et al. Interferon gene transfer by a hepatitis B virus vector efficiently suppresses wild-type virus infection. Proc Natl Acad Sci U S A 1999; 96: 10 818-10 823.
3. Sung VM, Lai MM. Murine retroviral pseudotype virus containing hepatitis B virus large and small surface antigens confers specific tropism for primary human hepatocytes: a potential liver-specific targeting system. J Virol 2002; 76: 912-917.
4. Ponder KP, Dunbar RP, Wilson DR, et al. Evaluation of relative promoter strength in primary hepatocytes using optimized lipofection. Hum Gene Ther 1991; 2: 41-52.
5. Armentano D, Thompson AR, Darlington G, et al. Expression of human factor IX in rabbit hepatocytes by retrovirus-mediated gene transfer: potential for gene therapy of hemophilia B. Proc Natl Acad Sci U S A 1990; 87: 6141-6145.
6. Kay MA, Baley P, Rothenberg S, et al. Expression of human alpha 1-antitrypsin in dogs after autologous transplantation of retroviral transduced hepatocytes. Proc Natl Acad Sci U S A 1992; 89: 89-93.
7. Guo ZS, Wang LH, Eisensmith RC, et al. Evaluation of promoter strength for hepatic gene expression in vivo following adenovirus-mediated gene transfer. Gene Ther 1996; 3: 802-810.
8. Kay MA, Li Q, Liu TJ, et al. Hepatic gene therapy: persistent expression of human alpha 1-antitrypsin in mice after direct gene delivery in vivo. Hum Gene Ther 1992; 3: 641-647.
9. Tavill AS. The synthesis and degradation of liver-produced proteins. Gut 1972; 13: 225-241.
10. Hafenrichter DG, Wu X, Rettinger SD, et al. Quantitative evaluation of liver-specific promoters from retroviral vectors after in vivo transduction of hepatocytes. Blood 1994; 84: 3394-3404.
11. Hafenrichter DG, Ponder KP, Rettinger SD, et al. Liver-directed gene therapy: evaluation of liver specific promoter elements. J Surg Res 1994; 56: 510-517.
12. Yoffe B, Burns DK, Bhatt HS, et al. Extrahepatic hepatitis B virus DNA sequences in patients with acute hepatitis B infection. Hepatology 1990; 12: 187-192.
13. Feray C, Zignego AL, Samuel D, et al. Persistent hepatitis B virus infection of monorruclear blood cells without concomitant liver infection. The liver transplantation model. Transplantation 1990; 49: 1155-1158.
14. Loser P, Sandig V, Kirillova I, et al. Evaluation of HBV promoters for use in hepatic gene therapy. Biol Chem Hoppe Seyler 1996; 377: 187-193.
15. Sandig V, Loser P, Lieber A, et al. HBV-derived promoters direct liver-specific expression of an adenovirally transduced LDL receptor gene. Gene Ther 1996; 3: 1002-1009.
16. Naldini L, Blomer U, Gallay P, et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 1996; 272: 263-267.
17. Kafri T, Blomer U, Peterson DA, et al. Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors. Nat Gen 1997; 17: 314-317.
18. Ohashi K, Park F, Schwall R, et al. Efficient gene transduction to cultured hepatocytes by HIV-1 derived lentiviral vector. Transplant Proc 2002; 34: 1431-1433.
19. Zufferey R, Dull T, Mandel RJ, et al. Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J Virol 1998; 72: 9873-9880.
20. Okuyama T, Huber RM, Bowling W, et al. Liver-directed gene therapy: a retroviral vector with a complete LTR and the ApoE enhancer-alpha 1-antitrypsin promoter dramatically increases expression of human alpha 1-antitrypsin in vivo. Hum Gene Ther 1996; 7: 637-645.
21. Zufferey R, Nagy D, Mandel RJ, et al. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat Biotechnol 1997; 15: 871-875.
22. Chen C, Okayama H. High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol 1987; 7: 2745-2752.
23. Wilson JM, Chowdhury NR, Grossman M, et al. Temporary amelioration of hyperlipidemia in low density lipoprotein receptor-deficient rabbits transplanted with genetically modified hepatocytes. Proc Natl Acad Sci U S A 1990; 87: 8437-8441.
24. Perlmutter DH, Cole FS, Kilbridge P, et al. Expression of the alpha 1-proteinase inhibitor gene in human monocytes and macrophages. Proc Natl Acad Sci U S A 1985; 82: 795-799.
25. Molmenti EP, Perlmutter DH, Rubin DC. Cell-specific expression of alpha 1-antitrypsin in human intestinal epithelium. J Clin Invest 1993; 92: 2022-2034.
26. Hu C, Perlmutter DH. Cell-specific involvement of HNF-1beta in alpha (1)-antitrypsin gene expression in human respiratory epithelial cells. Am J Physiol Lung Cell Mol Physiol 2002; 282: L757-765.
27. Simonet WS, Bucay N, Lauer SJ, et al. A far-downstream hepatocyte-specific control region directs expression of the linked human apolipoprotein E and C-I genes in transgenic mice. J Biol Chem 1993; 268: 8221-8229.
28. Ganem D, Varmus HE. The molecular biology of the hepatitis B viruses. Annu Rev Biochem 1987; 56: 651-693.
29. Antonucci TK, Rutter WJ. Hepatitis B virus (HBV) promoters are regulated by the HBV enhancer in a tissue-specific manner. J Virol 1989; 63: 579-583.
30. Raney AK, Milich DR, Easton AJ, et al. Differentiation-specific transcriptional regulation of the hepatitis B virus large surface antigen gene in human hepatoma cell lines. J Virol 1990; 64: 2360-2368.
31. Siddiqui A, Jameel S, Mapoles J. Transcriptional control elements of hepatitis B surface antigen gene. Proc Natl Acad Sci U S A 1986; 83: 566-570.
32. Honigwachs J, Faktor O, Dikstein R, et al. Liver-specific expression of hepatitis B virus is determined by the combined action of the core gene promoter and the enhancer. J Virol 1989; 63: 919-924.
33. Dikstein R, Faktor O, Ben-Levy R, et al. Functional organization of the hepatitis B virus enhancer. Mol Cell Biol 1990; 10: 3682-3689.
34. Guo WT, Bell KD, Ou JH. Characterization of the hepatitis B virus EnhI enhancer and X promoter complex. J Virol 1991; 65: 6686-6692.
35. Vannice JL, Levinson AD. Properties of the human hepatitis B virus enhancer: position effects and cell-type nonspecificity. J Virol 1988; 62: 1305-1313.
36. Yee JK. A liver-specific enhancer in the core promoter region of human hepatitis B virus. Science 1989; 246: 658-661.
37. Yuh CH, Ting LP. Differentiated liver cell specificity of the second enhancer of hepatitis B virus. J Virol 1993; 67: 142-149.
38. Hu KQ, Siddiqui A. Regulation of the hepatitis B virus gene expression by the enhancer element I. Virology 1991; 181: 721-726.
39. Bulla. GA, Siddiqui A. The hepatitis B virus enhancer modulates transcription of the hepatitis B virus surface antigen gene from an internal location. J Virol 1988; 62: 1437-1441.
40. Seppen J, Rijnberg M, Cooreman MP, et al. Lentiviral vectors for efficient transduction of isolated primary quiescent hepatocytes. J Hepatol 2002; 36: 459-465.
41. Huang ZM, Yen TS. Role of the hepatitis B virus posttranscriptional regulatory element in export of intronless transcripts. Mol Cell Biol 1995; 15: 3864-3869.